Diagnostic testing and antibiotic utilization among inpatients evaluated for coronavirus disease 2019 (COVID-19) pneumonia.

Megan R WimmerMeggie GriffinAlex Peterson-WeberLucas T SchulzAshlee G Hamel Rebecca J SchweiKaren FongDonna R BurgessMeghan BrettCory M HaleMarisa K Holubar Rupali JainRachel LarryEmily S SpivakHelen NewlandJessica NjokuMichael PostelnickCarla WalravenMichael S Pulia

Published in: Infection control and hospital epidemiology (2023)

We evaluated diagnostic test and antibiotic utilization among 252 patients from 11 US hospitals who were evaluated for coronavirus disease 2019 (COVID-19) pneumonia during the severe acute respiratory coronavirus virus 2 (SARS-CoV-2) omicron variant pandemic wave. In our cohort, antibiotic use remained high (62%) among SARS-CoV-2-positive patients and even higher among those who underwent procalcitonin testing (68%).

Keyphrases

sars cov
coronavirus disease
respiratory syndrome coronavirus
end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
peritoneal dialysis
prognostic factors
healthcare
intensive care unit
acute respiratory distress syndrome